Computational approaches for the design of protein–protein interaction inhibitors

[1]  Alexander D. MacKerell,et al.  Computational evaluation of protein-small molecule binding. , 2009, Current opinion in structural biology.

[2]  A Srinivas Reddy,et al.  Virtual screening in drug discovery -- a computational perspective. , 2007, Current protein & peptide science.

[3]  Alexander D. MacKerell,et al.  Consideration of Molecular Weight during Compound Selection in Virtual Target-Based Database Screening , 2003, J. Chem. Inf. Comput. Sci..

[4]  Alexander D. MacKerell,et al.  Computational ligand-based rational design: Role of conformational sampling and force fields in model development. , 2011, MedChemComm.

[5]  Alexander D. MacKerell,et al.  Automated Selection of Compounds with Physicochemical Properties To Maximize Bioavailability and Druglikeness , 2011, J. Chem. Inf. Model..

[6]  I. Kuntz,et al.  DOCK 6: combining techniques to model RNA-small molecule complexes. , 2009, RNA.

[7]  A. Melnick,et al.  A peptomimetic inhibitor of BCL6 with potent antilymphoma effects in vitro and in vivo. , 2009, Blood.

[8]  Alexander D. MacKerell,et al.  Reproducing Crystal Binding Modes of Ligand Functional Groups Using Site-Identification by Ligand Competitive Saturation (SILCS) Simulations , 2011, J. Chem. Inf. Model..

[9]  Jianpeng Ma,et al.  CHARMM: The biomolecular simulation program , 2009, J. Comput. Chem..

[10]  Lingle Wang,et al.  Ligand binding to protein-binding pockets with wet and dry regions , 2011, Proceedings of the National Academy of Sciences.

[11]  Alexander D. MacKerell,et al.  Computational Fragment-Based Binding Site Identification by Ligand Competitive Saturation , 2009, PLoS Comput. Biol..

[12]  Manuel Urbano-Cuadrado,et al.  Computational medicinal chemistry in fragment-based drug discovery: what, how and when. , 2011, Future medicinal chemistry.

[13]  Alexander D. MacKerell.  Empirical force fields for biological macromolecules: Overview and issues , 2004, J. Comput. Chem..

[14]  Alexander D. MacKerell,et al.  A small-molecule inhibitor of BCL6 kills DLBCL cells in vitro and in vivo. , 2010, Cancer cell.

[15]  Alexander D. MacKerell,et al.  Balancing target flexibility and target denaturation in computational fragment‐based inhibitor discovery , 2012, J. Comput. Chem..

[16]  Alexander D. MacKerell,et al.  Binding Response: A Descriptor for Selecting Ligand Binding Site on Protein Surfaces , 2007, J. Chem. Inf. Model..

[17]  Christopher R. Corbeil,et al.  Towards the development of universal, fast and highly accurate docking/scoring methods: a long way to go , 2008, British journal of pharmacology.

[18]  P. Ertl,et al.  Computational analysis of structure-activity relationships. , 2010, Progress in medicinal chemistry.

[19]  Robert P Sheridan,et al.  Why do we need so many chemical similarity search methods? , 2002, Drug discovery today.

[20]  Thomas Seidel,et al.  Strategies for 3D pharmacophore-based virtual screening. , 2010, Drug discovery today. Technologies.